Kang et al. (111) recently showed that the GLP-1 agonist Exd-4 improves tau hyperphosphorylation and cognitive impairment in T2DM by acting on the Wnt/β-catenin/NeuroD1 pathway. This evidence concerns the gene GCG and type 2 diabetes mellitus.